Someone diagnosed with HIV in the UK today, started on treatment promptly and remaining engaged with care, has a life expectancy approaching that of the general population. This is one of the largest changes in modern medicine and it is still not widely known, including among people who have just been diagnosed and are working from information that was accurate in 1996.
What does the evidence show?
Cohort studies across Europe and North America have tracked life expectancy in people on antiretroviral treatment over successive eras, and each generation of drugs has narrowed the gap. For people who start treatment early with a good CD4 count and maintain suppression, projected life expectancy is now close to that of comparable people without HIV. The remaining difference is largely explained by factors other than the virus itself.
What is the biggest variable?
Late diagnosis, without much competition. Someone diagnosed with a CD4 count below three hundred and fifty, and particularly below two hundred, has a measurably worse outlook than someone diagnosed early, because immune damage sustained before treatment is not always fully reversible and because they are at immediate risk of serious infections. A substantial proportion of UK diagnoses are still late, which is the strongest argument for routine testing regardless of symptoms.
What else affects the outcome?
Smoking is the single largest modifiable factor, and it takes more years from people living with HIV than HIV itself now does. Cardiovascular disease, liver disease from hepatitis co-infection or alcohol, and untreated mental health problems all contribute. Staying engaged with care matters enormously: people who disengage and re-present years later account for a disproportionate share of poor outcomes.
Does HIV cause other conditions?
Chronic low-level inflammation persists even on effective treatment, and this appears to contribute to a modestly increased risk of cardiovascular disease, kidney problems, reduced bone density and some cancers, with these conditions tending to appear somewhat earlier than in the general population. The effect is real but modest, and much smaller than that of smoking. This is why clinic appointments increasingly cover blood pressure, cholesterol, glucose and bone health rather than only viral load.
What does this mean practically?
The health advice for someone living with HIV is largely the same as for anyone else, applied with a bit more attention. Stop smoking, since the benefit is larger for you than for most people. Keep blood pressure and cholesterol under review. Stay physically active. Drink within sensible limits, particularly with hepatitis co-infection. Attend your appointments even during the years when nothing seems to be happening.
What about quality of life rather than length?
The harder question. Depression and anxiety are more common in people living with HIV than in the general population, and stigma, isolation and the ongoing work of managing disclosure account for a good deal of that. These are treatable and worth raising with the clinic, which is used to the conversation and can refer to psychology or peer support.
What should someone newly diagnosed take from this?
That the medical outlook is good and that the immediate task is straightforward: start treatment, reach undetectable, keep attending. The emotional adjustment takes longer than the clinical one and is not a sign of coping badly. Most of the risk that remains sits in things you can influence, which is a considerably better position than it sounds at the point of diagnosis.
Does this apply to everyone equally?
No, and it is worth being honest about that. The best outcomes belong to people diagnosed early, treated promptly and able to stay engaged with care. Outcomes are worse where poverty, insecure housing, immigration difficulties, addiction or untreated mental illness make consistent engagement hard. These are social problems rather than viral ones, which is why clinic health advisers spend as much time on housing and benefits as on medication.
How does this compare with other conditions?
Treated HIV now sits alongside conditions such as well-controlled diabetes in terms of the demands it makes and the outlook it carries. That comparison is not a minimisation of what a diagnosis feels like, but it is the accurate clinical framing, and it is a long way from the picture most people still hold.
What should you actually do with this information?
Test regularly so that if it happens, it happens early. That single behaviour accounts for more of the difference in outcomes than anything that follows a diagnosis.